Total Payments
$4,980
2024 Payments
$777.12
Companies
22
Transactions
166
Medicare Patients
712
Medicare Billing
$70,812
Payment Breakdown by Category
Food & Beverage$4,938 (99.1%)
Other$30.00 (0.6%)
Education$12.35 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,938 | 164 | 99.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30.00 | 1 | 0.6% |
| Education | $12.35 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,788 | 44 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $912.43 | 17 | $0 (2024) |
| Novo Nordisk Inc | $752.34 | 26 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $382.98 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $236.49 | 11 | $0 (2024) |
| Amgen Inc. | $175.27 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $168.48 | 10 | $0 (2024) |
| Amarin Pharma Inc. | $84.98 | 6 | $0 (2021) |
| Electromed, Inc. | $76.39 | 8 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $54.09 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $777.12 | 39 | AstraZeneca Pharmaceuticals LP ($213.35) |
| 2023 | $515.15 | 27 | Bayer Healthcare Pharmaceuticals Inc. ($108.76) |
| 2022 | $716.20 | 22 | Novo Nordisk Inc ($287.86) |
| 2021 | $865.08 | 43 | AstraZeneca Pharmaceuticals LP ($246.87) |
| 2020 | $197.49 | 14 | AstraZeneca Pharmaceuticals LP ($71.55) |
| 2019 | $491.19 | 6 | Novartis Pharmaceuticals Corporation ($249.79) |
| 2018 | $10.68 | 1 | AstraZeneca Pharmaceuticals LP ($10.68) |
| 2017 | $1,407 | 14 | AstraZeneca Pharmaceuticals LP ($679.71) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Cardio-renal | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Diabetes | ||||||
| 10/26/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.36 | General |
| Category: HFCWO | ||||||
| 10/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.06 | General |
| Category: HFCWO | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.02 | General |
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Cardio-renal | ||||||
| 07/19/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.14 | General |
| 07/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: DIABETES | ||||||
| 06/20/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $23.91 | General |
| Category: HFCWO | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $91.17 | General |
| Category: Respiratory | ||||||
| 06/01/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.27 | General |
| Category: HFCWO | ||||||
| 05/26/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $2.45 | General |
| Category: HFCWO | ||||||
| 05/22/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $23.75 | General |
| Category: HFCWO | ||||||
| 05/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 05/18/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.12 | General |
| Category: HFCWO | ||||||
| 05/16/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $7.47 | General |
| Category: HFCWO | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 223 | 318 | $41,445 | $21,194 |
| 2022 | 6 | 115 | 150 | $19,880 | $11,381 |
| 2021 | 8 | 202 | 330 | $37,280 | $20,995 |
| 2020 | 7 | 172 | 232 | $40,030 | $17,243 |
Total Patients
712
Total Services
1,030
Medicare Billing
$70,812
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 83 | $12,450 | $5,378 | 43.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $9,250 | $5,295 | 57.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 44 | $8,530 | $4,061 | 47.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 39 | 39 | $5,850 | $3,458 | 59.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 17 | $1,530 | $1,223 | 79.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 15 | 19 | $1,995 | $894.89 | 44.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 20 | $800.00 | $679.40 | 84.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 19 | 45 | $900.00 | $144.45 | 16.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 14 | 14 | $140.00 | $61.46 | 43.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 40 | $6,200 | $4,143 | 66.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $4,750 | $2,797 | 58.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 32 | $4,800 | $2,135 | 44.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 21 | 21 | $3,150 | $1,848 | 58.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $440.00 | $370.59 | 84.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 12 | 27 | $540.00 | $87.21 | 16.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 75 | $11,625 | $7,848 | 67.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 71 | $8,875 | $4,353 | 49.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $5,000 | $2,982 | 59.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 19 | 62 | $4,650 | $2,274 | 48.9% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 27 | 27 | $4,050 | $1,937 | 47.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 16 | 16 | $1,440 | $1,036 | 71.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $920.00 | $448.23 | 48.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 17 | 36 | $720.00 | $118.08 | 16.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 91 | $17,420 | $8,211 | 47.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 24 | 37 | $9,065 | $2,907 | 32.1% |
About Dr. Hemlata Bhatia, MD
Dr. Hemlata Bhatia, MD is a Family Medicine healthcare provider based in Bloomfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801811310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hemlata Bhatia, MD has received a total of $4,980 in payments from pharmaceutical and medical device companies, with $777.12 received in 2024. These payments were reported across 166 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,938).
As a Medicare-enrolled provider, Bhatia has provided services to 712 Medicare beneficiaries, totaling 1,030 services with total Medicare billing of $70,812. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bloomfield, NJ
- Active Since 07/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801811310
Products in Payments
- FARXIGA (Drug) $1,254
- ENTRESTO (Drug) $869.60
- Ozempic (Drug) $432.36
- Kerendia (Drug) $382.98
- BREZTRI (Drug) $283.07
- VERQUVO (Drug) $133.84
- FASENRA (Biological) $123.09
- JARDIANCE (Drug) $119.74
- RYBELSUS (Drug) $113.46
- Repatha (Biological) $113.21
- BYDUREON (Drug) $112.73
- Rybelsus (Drug) $107.65
- Xultophy 100/3.6 (Drug) $98.87
- Vascepa (Drug) $84.98
- PRADAXA (Drug) $80.25
- SMARTVEST (Device) $76.39
- Otezla (Drug) $62.06
- Livalo (Drug) $54.09
- Xenleta (Drug) $51.19
- QUVIVIQ (Drug) $45.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bloomfield
Gilberto Ramirez, Md, MD
Family Medicine — Payments: $13,439
Family Medicine $13,439
Dr. Rochelle Collins, Do, DO
Family Medicine — Payments: $5,318
Family Medicine $5,318
Kennett Asher, D. O, D. O
Family Medicine — Payments: $4,833
Family Medicine $4,833
Yasmen Srour, M.d, M.D
Family Medicine — Payments: $2,886
Family Medicine $2,886
Christine Hanna, Md, MD
Family Medicine — Payments: $2,115
Family Medicine $2,115
Dr. Donald Wirtanen, D.o, D.O
Family Medicine — Payments: $1,388
Family Medicine $1,388